Logotype for Theralase Technologies Inc

Theralase Technologies (TLT) investor relations material

Theralase Technologies Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Theralase Technologies Inc
Q2 2025 earnings summary25 Aug, 2025

Executive summary

  • Revenue for the six months ended June 30, 2025, increased 12% year-over-year to $310,933, driven by higher Canadian sales, while US and international sales declined significantly.

  • Net loss for the period was $2,423,234, slightly higher than the $2,400,461 loss in the prior year, with the Drug Division accounting for 79% of the loss.

  • The company continues to invest heavily in R&D, particularly in its Drug Division, advancing late-stage clinical trials for Ruvidar® in bladder cancer and preclinical programs for other oncology indications.

  • Material uncertainties exist regarding the company's ability to continue as a going concern, with ongoing reliance on external financing and negative working capital.

Financial highlights

  • Gross margin improved to 42% of revenue (up from 33% in 2024), as cost of sales decreased to 58% of revenue.

  • Operating expenses totaled $2,594,791, with R&D representing 57% of total operating costs.

  • Cash and cash equivalents at June 30, 2025, were $46,325, down from $268,757 at year-end 2024.

  • Shareholders’ equity declined to $1,276,397 from $2,067,448 at December 31, 2024.

  • Net investment in leases was $1,359,590, with 88 active contracts and timely payments.

Outlook and guidance

  • Management plans to complete full enrollment of 90 patients in the Phase II bladder cancer study by Q3 2025, with final data and regulatory submissions targeted for 2026.

  • The company is actively seeking additional financing and exploring strategic partnerships for commercialization.

  • Ongoing R&D will focus on expanding the oncology pipeline, including clinical translation of Rutherrin® for multiple cancer indications.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Theralase Technologies earnings date

Logotype for Theralase Technologies Inc
Q3 202528 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Theralase Technologies earnings date

Logotype for Theralase Technologies Inc
Q3 202528 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Theralase Technologies Inc is a Canada-based medical technology company focused on the development and commercialization of laser systems for therapeutic and clinical applications. The company operates in two main segments: therapeutic laser technology for pain management and photo-dynamic therapy for the treatment of cancer. Its products are designed for use by healthcare professionals in physiotherapy, chiropractic, and oncology settings. The company is headquartered in Toronto, Canada, and its shares are listed on the TSXV.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage